|
|
Article: Weight loss drug may reduce threat of type 2 diabetes.
- Article from:
- Diabetes Week
- Article date:
- January 19, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 JAN 19 - (NewsRx.com & NewsRx.net) -- According to results from the landmark XENDOS study published in Diabetes Care, patients who achieve weight loss with Xenical have a significantly reduced risk of developing type 2 diabetes. This is the first time ever a weight loss medication has achieved this result.
XENDOS is the largest and longest study to date of a weight loss medication, treating 3,304 patients for four years with Xenical plus lifestyle changes, or lifestyle changes alone. It is also the first study to assess whether treatment with a weight loss medication, Xenical, can reduce the risk of developing type 2 diabetes.
The study showed that ...